Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Infection Type (Blood Stream Infection, Surgical Site Infection, Urinary Tract Infection, Pneumonia), By Test Type (Molecular Diagnostics, Blood Tests, Urinalysis), By Region And Trend Analysis From 2012 To 2022

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Hospital Acquired Infections Diagnostic Market - Industry Summary and Key Buying Criteria, 2012 - 2020
Chapter 3. Hospital Acquired Infections Diagnostic Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Hospital Acquired Infections Diagnostic: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Growing geriatric population
3.3.1.2. Increasing resistance to antibiotics
3.3.1.3. Escalating demand of HAI diagnostics from middle- and low- income countries
3.3.2. Market restraint analysis
3.3.2.1. Declining demand from developed countries
3.4. Hospital Acquired Infections Diagnostic Market: Industry trend analysis
3.5. Hospital Acquired Infections Diagnostic Market - PESTEL Analysis
3.6. Hospital Acquired Infections Diagnostic Market Industry analysis - Porter's Five Forces Model
Chapter 4. Hospital Acquired Infections Diagnostic Infection Type Outlook
4.1. Hospital Acquired Infections Diagnostic Market Revenue Share (%) Analysis, by Infection Type, 2014 & 2022
4.2. Urinary Tract Infection (UTI)
4.2.1.尿路感染诊断市场revenue, by region, 2012 to 2022 (USD Million)
4.3. Blood Stream Infection (BSI)
4.3.1. Blood stream infection diagnostics market revenue, by region, 2012 to 2022 (USD Million)
4.4. Surgical Site Infection (SSI)
4.4.1. Surgical site infection diagnostics market revenue, by region, 2012 to 2022 (USD Million)
4.5. Pneumonia
4.5.1. Pneumonia diagnostics market revenue, by region, 2012 to 2022 (USD Million)
4.6. Other Hospital Acquired Infections
4.6.1. Other hospital acquired infections diagnostics market revenue, by region, 2012 to 2022 (USD Million)
Chapter 5. Hospital Acquired Infections Diagnostic Test Type Outlook
5.1. Hospital Acquired Infections Diagnostic Market Revenue Share (%) Analysis, by Test Type, 2014 & 2022
5.2. Molecular Diagnostics
5.2.1. Molecular diagnostics market revenue, by region, 2012 to 2022 (USD Million)
5.3. Others in-vitro diagnostics tests
5.3.1. Other diagnostics tests market revenue, by region, 2012 to 2022 (USD Million)
Chapter 6. Hospital Acquired Infections Diagnostic Regional Outlook
6.1. Hospital Acquired Infections Diagnostic Market Share (%) Analysis, by Region, 2014 & 2022
6.2. North America
6.2.1.美国
6.2.1.1. The U.S. Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.2.1.2. The U.S. Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.2.2. Canada
6.2.2.1. Canada Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.2.2.2. Canada Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.3.1.2. Germany Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.3.2. The U.K.
6.3.2.1. The U.K. Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.3.2.2. The U.K. Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.4. Asia Pacific
6.4.1. China
6.4.1.1. China Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.4.1.2. China Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.4.2. India
6.4.2.1. India Hospital Acquired Infections market, by infection type, 2012 - 2022 (USD Million)
6.4.2.2. India Hospital Acquired Infections market, by test type, 2012 - 2022 (USD Million)
6.5. MEA
6.5.1. Nigeria
6.5.1.1.倪geria Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.5.1.2. Nigeria Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Brazil Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.6.1.2. Brazil Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
6.6.2. Mexico
6.6.2.1. Mexico Hospital Acquired Infections Diagnostic market, by infection type, 2012 - 2022 (USD Million)
6.6.2.2. Mexico Hospital Acquired Infections Diagnostic market, by test type, 2012 - 2022 (USD Million)
Chapter 7. Competitive Landscape
7.1. bioMérieux
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Abbott Laboratories
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Alere, Inc.
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Roche AG
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Siemens Healthcare
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Becton Dickenson
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Cepheid Inc.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Thermo Fisher Scientific
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Seegene, Inc.
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. Qiagen
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives

List of Tables

1. HAI Diagnostics - Industry Snapshot & Key Buying Criteria, 2012 - 2022
2. HAI diagnostics - Key market driver analysis
3. HAI diagnostics - Key market restraint analysis
4. Global HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
5. Global HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
6. Global HAI diagnostics market revenue, by region, 2012 - 2022 (USD Million)
7. North America HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
8. North America HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
9. U.S.HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
10.U.S. HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
11. Canada HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
12. Europe HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
13. Europe HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
14. Germany HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
15. Germany HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
16. U.K.HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
17. U.K. HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
18. Asia Pacific HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
19. Asia Pacific HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
20. China HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
21. India HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
22. Latin America HAI diagnostics market revenue, by infection type, 2012 - 2022 (USD Million)
23. Latin America HAI diagnostics market revenue, by test type, 2012 - 2022 (USD Million)
24. Brazil HAI diagnostics market revenue, by infection type application, 2012 - 2022 (USD Million)
25. Brazil HAI diagnostics market revenue, by test type application, 2012 - 2022 (USD Million)
26. Mexico HAI diagnostics market revenue, by infection type application, 2012 - 2022 (USD Million)
27. Mexico HAI diagnostics market revenue, by test type application, 2012 - 2022 (USD Million)
28. MEA HAI diagnostics market revenue, by infection type application, 2012 - 2022 (USD Million)
29. MEA HAI diagnostics market revenue, by test type application, 2012 - 2022 (USD Million)
30. Nigeria HAI diagnostics market revenue, by infection type application, 2012 - 2022 (USD Million)
31. Nigeria HAI diagnostics market revenue, by test type application, 2012 - 2022 (USD Million)

List of Figures

1. Global HAI Diagnostics: Market segmentation
2. Global HAI diagnostics, 2012 - 2022 (USD Million)
3. Global HAI diagnostics market: Industry trend analysis
4. Global HAI diagnostics market: PESTEL analysis
5. Global HAI diagnostics market: Porter’s analysis
6. Key Opportunities Prioritized
7. HAI diagnostics market revenue share by infection type, 2014 & 2022
8. HAI diagnostics market revenue share by test type, 2014 & 2022
9. Urinary Tract Infection HAI diagnostics market revenue, 2012 to 2022 (USD Million)
10.血流感染海迪亚gnostics market revenue, 2012 to 2022 (USD Million)
11. Surgical Site Infection HAI diagnostics market revenue, 2012 to 2022 (USD Million)
12. Pneumonia HAI diagnostics market revenue, 2012 to 2022 (USD Million)
13. Other HAI diagnostics market revenue, 2012 to 2022 (USD Million)
14. Molecular tests HAI diagnostics market revenue, 2012 to 2022 (USD Million)
15. Other HAI diagnostics market revenue, 2012 to 2022 (USD Million)
16. HAI diagnostics market share, by region, 2014 & 2022